Literature DB >> 11342470

Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina.

G Liuzzo1, D J Angiolillo, A Buffon, V Rizzello, C Colizzi, F Ginnetti, L M Biasucci, A Maseri.   

Abstract

BACKGROUND: C-reactive protein (CRP) plasma levels have been associated with short- and long-term occurrence of coronary events. We investigated whether circulating inflammatory cell responsiveness to low-grade stimuli could contribute to the reported association between CRP and coronary events. METHODS AND
RESULTS: We studied 32 patients with unstable angina who were followed for 24 months and were free of symptoms for 6 months (group 1): 19 patients had persistently high CRP levels (>0.3 mg/dL) (group 1A); 13 patients had normal CRP levels (group 1B). During the follow-up, 12 (63%) group 1A but no group 1B patients developed an infarction or recurrence of unstable angina (P<0.001). Eighteen patients with chronic stable angina (group 2) and 18 healthy subjects (group 3) were studied as controls. Interleukin (IL)-6 production (median, range) by peripheral blood mononuclear cells after 4 hours of in vitro stimulation with 1 ng/mL lipopolysaccharide (LPS) was significantly higher in group 1A (4526 pg/mL, 3042 to 10 583 pg/mL) than in group 1B (1752 pg/mL, 75 to 3981 pg/mL), group 2 (707 pg/mL, 41 to 3275 pg/mL), and group 3 (488 pg/mL, 92 to 3503 pg/mL) (all P<0.001). No significant differences were observed among the other groups. IL-6 production after LPS-challenge was correlated with baseline CRP levels (r=0.42, P=0.005).
CONCLUSIONS: Mononuclear cells of patients with recurrent phases of instability exhibit an enhanced production of IL-6 in response to low-dose of LPS, correlated with baseline CRP levels, 6 months after the last acute event. This persisting enhanced acute-phase responsiveness may help explain the association between CRP and acute coronary events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342470     DOI: 10.1161/01.cir.103.18.2236

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina.

Authors:  L M Biasucci; M Lombardi; M Piro; G Di Giannuario; G Liuzzo; F Crea
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 2.  The expression and functions of toll-like receptors in atherosclerosis.

Authors:  Jennifer E Cole; Ektoras Georgiou; Claudia Monaco
Journal:  Mediators Inflamm       Date:  2010-06-24       Impact factor: 4.711

Review 3.  CD14 and toll-like receptor 4: a link between infection and acute coronary events?

Authors:  R Arroyo-Espliguero; P Avanzas; S Jeffery; J C Kaski
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

4.  Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.

Authors:  Leah B Kosyakovsky; Federico Angriman; Emma Katz; Neill K Adhikari; Lucas C Godoy; John C Marshall; Bruno L Ferreyro; Douglas S Lee; Robert S Rosenson; Naveed Sattar; Subodh Verma; Augustin Toma; Marina Englesakis; Barry Burstein; Michael E Farkouh; Margaret Herridge; Dennis T Ko; Damon C Scales; Michael E Detsky; Lior Bibas; Patrick R Lawler
Journal:  Intensive Care Med       Date:  2021-08-09       Impact factor: 17.440

5.  Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan study.

Authors:  Yasuyoshi Takei; Marco R Di Tullio; Shunichi Homma; Bernadette Boden-Albala; Tatjana Rundek; Ralph L Sacco; Grace Berry; Rui Liu; Zhezhen Jin; Kazuo Eguchi; Mitchell S V Elkind
Journal:  Am J Hypertens       Date:  2009-04-23       Impact factor: 2.689

Review 6.  Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.

Authors:  Amos Baruch; Nicholas van Bruggen; Juyong Brian Kim; Joshua E Lehrer-Graiwer
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

7.  Innate immunity and monocyte-macrophage activation in atherosclerosis.

Authors:  Joseph Shalhoub; Mika A Falck-Hansen; Alun H Davies; Claudia Monaco
Journal:  J Inflamm (Lond)       Date:  2011-04-28       Impact factor: 4.981

8.  Acute coronary syndromes: from the laboratory markers to the coronary vessels.

Authors:  Palazzuoli Alberto; Iovine Francesca; Scali Chiara; Nuti Ranuccio
Journal:  Biomark Insights       Date:  2007-02-07

9.  Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery disease.

Authors:  Jan-Willem E M Sels; Ellen H A M Elsenberg; Imo E Hoefer; Anton Jan van Zonneveld; Johan Kuiper; J Wouter Jukema; Nico H J Pijls; Gerard Pasterkamp
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

10.  Toll-Like Receptor induced CD11b and L-selectin response in patients with coronary artery disease.

Authors:  Ellen H A M Elsenberg; Marieke A Hillaert; Hester M den Ruijter; Jan-Willem E M Sels; Vincent P W Scholtes; Hendrik M Nathoe; Johan Kuiper; J Wouter Jukema; Pieter A Doevendans; Gerard Pasterkamp; Imo E Hoefer
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.